- Home
- SDA vs HBIO Comparison
SDA vs HBIO Comparison
Compare SDA & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SDA | HBIO |
|---|---|---|
| Founded | 2007 | 1901 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.6M | 26.5M |
| IPO Year | 2022 | 2000 |
Fundamental Metrics
Financial Performance| Metric | SDA | HBIO |
|---|---|---|
| Price | $0.36 | $9.23 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $10.25 |
| AVG Volume (30 Days) | ★ 27.0M | 17.8K |
| Earning Date | 12-17-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $116,176,000.00 |
| Revenue This Year | $21.66 | $3.75 |
| Revenue Next Year | $11.14 | $5.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.13 | $0.40 |
| 52 Week High | $2.45 | $9.32 |
Technical Indicators
Market Signals| Indicator | SDA | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 52.76 | 67.38 |
| Support Level | $0.27 | $5.91 |
| Resistance Level | $0.50 | N/A |
| Average True Range (ATR) | 0.08 | 0.43 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 65.45 | 76.67 |
Price Performance
Historical ComparisonAbout SDA SunCar Technology Group Inc.
SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform. Revenues from its continuing operations are mainly generated from providing auto eInsurance services, technology services, and auto services.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.